verapamil has been researched along with Cerebrovascular Moyamoya Disease in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 7 year old girl with moyamoya disease presented with progressive right arm and leg weakness and muteness." | 1.27 | Treatment of acute deficits of moyamoya disease with verapamil. ( Gebarski, SS; Goldstein, GW; McLean, MJ; van der Spek, AF, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McLean, MJ | 2 |
| Gebarski, SS | 2 |
| van der Spek, AF | 2 |
| Goldstein, GW | 2 |
2 other studies available for verapamil and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
Response of moyamoya disease to verapamil.
Topics: Arterial Occlusive Diseases; Child; Child, Preschool; Female; Humans; Male; Moyamoya Disease; Verapa | 1985 |
Treatment of acute deficits of moyamoya disease with verapamil.
Topics: Arterial Occlusive Diseases; Cerebral Angiography; Cerebrovascular Circulation; Child; Female; Human | 1985 |